These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23679245)

  • 1. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
    Chen Y; Wang X; Chen G; Dong C; Zhang D
    PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of β-catenin Expression in Breast Cancer Patients: a Meta-analysis.
    Zhang DP; Li XW; Lang JH
    Asian Pac J Cancer Prev; 2015; 16(14):5625-33. PubMed ID: 26320427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of survivin expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Tumour Biol; 2013 Aug; 34(4):2053-62. PubMed ID: 23690235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis.
    Chen W; Huang S; Shi K; Yi L; Liu Y; Liu W
    Cancer Control; 2021; 28():10732748211033743. PubMed ID: 34482737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.
    Jiang H; Li H
    BMC Cancer; 2021 Feb; 21(1):149. PubMed ID: 33568081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
    Li CY; Yuan P; Lin SS; Song CF; Guan WY; Yuan L; Lai RB; Gao Y; Wang Y
    Tumour Biol; 2013 Apr; 34(2):735-41. PubMed ID: 23269605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis.
    Chen J; Chen LJ; Zhou HC; Yang RB; Lu Y; Xia YL; Wu W; Hu LW
    Hepatogastroenterology; 2014; 61(130):518-24. PubMed ID: 24901174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
    Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
    Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis.
    Zhang QW; Liu L; Chen R; Wei YQ; Li P; Shi HS; Zhao YW
    Asian Pac J Cancer Prev; 2012; 13(6):2903-8. PubMed ID: 22938481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
    Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
    Ranogajec I; Jakić-Razumović J; Puzović V; Gabrilovac J
    Med Oncol; 2012 Jun; 29(2):561-9. PubMed ID: 21611838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
    Zhang Z; Luo G; Tang H; Cheng C; Wang P
    PLoS One; 2016; 11(11):e0165725. PubMed ID: 27812168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.
    Wang Y; Wei Y; Huang J; Li X; You D; Wang L; Ma X
    BMC Cancer; 2024 Aug; 24(1):1065. PubMed ID: 39210344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis.
    He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX
    J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.